Clinical Trials Logo

Osteonecrosis clinical trials

View clinical trials related to Osteonecrosis.

Filter by:

NCT ID: NCT06016634 Not yet recruiting - Sickle Cell Disease Clinical Trials

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Start date: March 2024
Phase: Phase 2
Study type: Interventional

A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis

NCT ID: NCT05795647 Recruiting - Clinical trials for Medication-related Osteonecrosis of the Jaw (MRONJ)

The PENTO Protocol in Medication-related Osteonecrosis of the Jaw

PENTO
Start date: February 29, 2024
Phase: Phase 2
Study type: Interventional

Medication-related osteonecrosis of the jaw (MRONJ) occurs after taking bisphosphonates or targeted therapies. It leads to a significant decrease in quality of life with pain, eating and chewing disorders, and malnutrition. Current treatments are only partially effective. PENTO (pentoxifylline and tocopherol) has been shown to be effective in maxillary osteoradionecrosis. The objective of this study is to evaluate the proportion of bone recovery in patients receiving PENTO in MRONJ at 12 months.

NCT ID: NCT05735561 Completed - Avascular Necrosis Clinical Trials

Proximal Humerus Fracture Dislocation Direction and Avascular Necrosis

PHF-D
Start date: February 15, 2023
Phase:
Study type: Observational

The purpose of the study is to see if there is a connection between a proximal humerus fracture dislocation direction and the likelihood of developing avascular necrosis. Utilizing a retrospective cohort from the last ten years we hope to bring consenting patients back for a single visit to have x-rays and complete patient reported outcome measures to assess for evidence of avascular necrosis.

NCT ID: NCT05734651 Recruiting - Osteoarthritis, Hip Clinical Trials

PROMIS Evaluation Study

Start date: February 9, 2023
Phase:
Study type: Observational [Patient Registry]

A total of 250 total hip arthroplasties (THA) are performed at the Bezirkskrankenhaus St. Johann. In a majority of those, implants from the company Falcon Medical (Austria) are used. Those implants are undergoing constant development and improvement. To guarantee their clinical performance, this clinical study is evaluating safety and efficacy of all implants produced by Falcon Medical. The purpose of this study is to evaluate the effcacy and safety of implants produced and distributed by Falcon Medical. All patients with primary THA and usage of a Falcon Medical implant are included. The outcome measures include intra-operative complications, early post-operative complications, revision for any cause and patient reported outcome (WOMAC questionnaire). All data is prospectively collected in a standardized fashion.

NCT ID: NCT05727696 Completed - Clinical trials for Avascular Necrosis of Lunate

A Comparative Study Between Radius and Capitate Shortening in Ulna Minus Variance Kienbock's Disease

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

1. Kienböck's disease refers to avascular necrosis of the lunate carpal bone, known as lunatomalacia. It was first recognized and described by Austrian radiologist Robert Kienböck's in 1910 2. The lunate is the central bone in the proximal row, and it articulates with the scaphoid, capitate, triquetrum, and occasionally the hamate. More proximally, the lunate is a component of the radiocarpal joint, and it also articulates with the ulna via the triangular fibrocartilage complex (TFCC) 3. The exact cause of Kienböck's is not known, though there are thought to be a number of factors predisposing a person to Kienböck's. Although there is no evidence that Kienböck's disease is inherited, it is possible that unidentified genetic factors could contribute to the development of the condition, It is multifactorial, related to the following variables:Ulnar negative variance (or ulna minus),Vascular supply to the lunate bone,Lunatemorphology,Radial inclination angle,multiple wrist trauma 4. Kienböck's disease is the second most common type of avascular necrosis of the carpal bones, preceded only by avascular necrosis of the scaphoid. The typically affected population is males aged 20-40 years 5. Patients usually present with unilateral pain over the dorsal aspect of the wrist, limited wrist motion, weakness, or a combination of the three. Wrist extension and axial loading exacerbate pain. Symptoms range from mild to debilitating. It is rarely bilateral, and trauma is often absent. Physical examination commonly reveals wrist swelling, tenderness over the expected location of the lunate, synovitis, and loss of grip strength 6. Kienböck's disease is a clinical and imaging diagnosis. Both radiography/computed tomography and magnetic resonance imaging (MRI) are highly specific. However, MRI is the most sensitive and detects radiographically occult cases

NCT ID: NCT05719935 Recruiting - Osteoarthritis Clinical Trials

The KinematX Midcarpal Total Wrist Arthroplasty Registry

Start date: April 26, 2021
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to learn about functional and patient reported outcomes in patient undergoing total wrist replacement with the KinematX total wrist replacement study. The main questions it aims to answer are: - What is the range of motion (flexion, extension, radial, ulnar, grip and pinch strength) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant. - What are the patient reported outcomes (PROMIS, PRWE, HSS wrist expectations) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant. - How do range of motion and patient reported outcomes change over the 10 years after total wrist replacement surgery? Participants will be followed according to standard of care and preoperative and post-operative information for up to 10 years after surgery will be collected and entered into an electronic data base. Patients are eligible to enroll into the registry before or after they have had their wrist replacement surgery.

NCT ID: NCT05706909 Recruiting - Avascular Necrosis Clinical Trials

The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

Genex
Start date: February 8, 2023
Phase:
Study type: Observational

The purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genex®.

NCT ID: NCT05684588 Completed - Osteonecrosis Clinical Trials

Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head

Covid-ON
Start date: November 15, 2021
Phase: N/A
Study type: Interventional

During the most recent pandemy COVID-19, various advises concerning complications following high corticosteroid doses administration were pubblished in 2020. However, evidence is lacking about the incidence of Non-traumatic osteonecrosis of the femoral head (ONFH) in patients experiencing COVID-19. The aim of the present proposal is to obtain a quantitative estimation of ONFH cases among patients previoulsy hospitalized and treated for COVID-19 at ASST-Papa Giovanni XXIII.

NCT ID: NCT05669066 Completed - Knee Osteoarthritis Clinical Trials

Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement

Start date: July 10, 2017
Phase: N/A
Study type: Interventional

The main purpose of this study is to look at whether meditation techniques can help reduce pain and opioid use after surgery.

NCT ID: NCT05666284 Recruiting - Hip Osteoarthritis Clinical Trials

Radiographic Changes and Clinical Implications of Implantation of Shortened Uncemented Femoral Stems in THA

THA
Start date: October 11, 2022
Phase:
Study type: Observational

The hip prosthesis market is constantly growing with the number of prostheses reaching 949,000 in 2019. Along with this, there is also an increase in interest in short stems also called shortened stems. Thus on Pubmed, in 5 years, 171 publications have been listed. Thus, it seems interesting to study and analyze the performance of the shortened stem used in the Department of Orthopedic Surgery and Traumatology of the University Hospitals of Strasbourg and to compare them with the results of the literature.